Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Feasibility Study for Improving Patient Access to Cancer Clinical Trials (iMPACT): A Financial Reimbursement Program for Patients in Cancer Therapeutic Clinical Trials

NCT03943082 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03943082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03943082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Feasibility Study for Improving Patient Access to Cancer Clinical Trials (iMPACT): A Financial Reimbursement Program for Patients in Cancer Therapeutic Clinical Trials
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Terminated
Start date
April 8, 2019
Completion date
October 26, 2021
Enrollment
252 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid cell neoplasm, malignant neoplasm